Clinical Omics – News and Features

Featuring expert insights, this article will reflect on recent progress in the multiomics research space, exploring workflow developments, technologies and applications.

A new version of the Human Protein Atlas has been released, featuring the Human Disease Blood Atlas, a pan-cancer strategy that depicts proteome signatures for specific types of cancer. The atlas was created using next-generation proteome profiling methods, and offers enthusiasm for the future of the clinical proteomics field.

Here we explore how biomarkers are driving the immuno-oncology landscape. We dive into cutting-edge biomarker research and the challenges facing the field.

Researchers have identified biological markers in triple-negative breast cancer that are associated with resistance to chemotherapy treatment.

Gas chromatography mass spectrometry (GC-MS) is an important technique in the analytical chemist's armory. In this article we explore how GC-MS and GC-MS/MS work, what they can tell us, their strengths, weaknesses and applications.

Scientists and clinicians from the University of Cambridge – supported by Cancer Research UK (CRUK) – have conducted the largest whole-genome sequencing analysis of cancer tumors to date.

In this interview, Dr. Daniel Hornburg discusses how engineered nanoparticles could help to bridge the gap between proteomics and genomics and transform cancer diagnostics.

In this article, we will explore some of the recent advances in proteomics and their potential wider impact.

A new study has adopted a multi-omics methodology to explore potential links between diet, the microbiome and the immune response in multiple sclerosis (MS). The results are published in EBioMedicine.

Single-cell technologies are transforming our knowledge of human health and disease. In this article, Gary Kruppa outlines the latest advances in single-cell proteomics.